Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acceptability of Pentasa Sachets vs Tablets in Children with Crohn's Disease
NCT00225810Phase 4Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Oct 2005
- Primary completion
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Salcrozine in Crohn's disease, sponsored by Ferring Pharmaceuticals. Started Oct 2005; status: completed.
02
Drugs
Salcrozine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00225810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00225810.